Search

Displaying results 8271 - 8280 of 10000 in total
  1. Drug

    Platycodon grandiflorus leaf

    go.drugbank.com/drugs/DB14356
    Investigational

    Platycodon grandiflorus leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Ilex paraguariensis leaf

    go.drugbank.com/drugs/DB14366
    Investigational

    Ilex paraguariensis leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    Camphor leaf oil

    go.drugbank.com/drugs/DB14378
    Investigational

    Camphor leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Synonyms: Camphor Oil Formosan Ho-sho Leaves, Camphor Oil, Formosan Ho-sho, Leaves
  4. Drug

    Dimethylcurcumin

    go.drugbank.com/drugs/DB06133
    Investigational

    Dimethylcurcumin is a synthetic chemical compound that is loosely based on a compound found in curcumin. It is a novel anti-androgen that enhances androgen receptor degradation.

  5. Drug

    Ocaperidone

    go.drugbank.com/drugs/DB06229
    Experimental

  6. Drug

    Lysozyme

    go.drugbank.com/drugs/DB13260
    Investigational

    Categories: Antiinfectives for Systemic Use
  7. Drug

    Darapladib

    go.drugbank.com/drugs/DB06311
    Investigational

  8. Drug

    Garden snail mucin

    go.drugbank.com/drugs/DB14244
    Investigational

    Garden snail mucin is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

  9. Drug

    Marine collagen, soluble

    go.drugbank.com/drugs/DB14246
    Investigational

    Marine collagen, soluble is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

  10. Drug

    Itepekimab

    go.drugbank.com/drugs/DB16206
    Investigational

    Itepekimab is under investigation in clinical trial NCT03546907 (Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-il-33 Mab) in Patients With Moderate-to-severe